THE CLINICAL FUTURE OF BIOPRINTING: FROM BIOFABRICATION TECHNOLOGIES TO NEXT-GENERATION REGENERATIVE THERAPIES
Tracks
SPEAKER'S ROOM 1: DOROTEA BARNÉS
| Wednesday, September 30, 2026 |
| 9:30 - 10:15 |
| SPEAKERS' CORNER 1: DOROTEA BARNÉS |
Details
Bioprinting is rapidly evolving from an emerging laboratory technology into a transformative clinical platform with the potential to redefine regenerative medicine. This roundtable will bring together key European stakeholders from biofabrication, robotics, clinical translation and advanced manufacturing to discuss how bioprinting can successfully move from research environments into real-world medical practice.Through complementary perspectives, the discussion will address the major challenges and opportunities facing the field: unmet clinical needs, in vivo bioprinting, robotic-assisted biofabrication, industrial scalability, regulatory pathways, hospital integration and next-generation regenerative therapies. The session aims to provide a realistic and strategic vision of how the clinical future of bioprinting can be built.
Details
Andrea Garcia
TECNALIA
.
Jesus Izco Zaratiegui
Bioproducts Diversification Manager
VISCOFAN
.
Luc Milbergue
Presidente
POIETIS Biosistems
.
Francisco Sánchez Margallo
Director Científico del CCMIJU
Centro de Cirugía de Mínima Invasión Jesús Usón (CCMIJU)
.
AM Conferences & Meetings, S.L. - C/ Espronceda, 27 - 28003 Madrid